Vutrisiran, sold under the brand name Amvuttra, is a medication used for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. From Wikipedia
The manager cites stock-specific catalysts to explain sector weakness, standout launches, portfolio exits.
